GE HealthCare Technologies (GEHC) Stock Forecast & Price Target
Score
GE HealthCare Technologies Inc. price target
| GEHC | |
|---|---|
| Low | $67.00 |
| Average | $81.14 |
| High | $95.00 |
| Upside vs current price | -2.3% |
The average target of $81.14 is -2.3% versus the current GEHC price of $83.02.
GE HealthCare Technologies Inc. analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 6 |
| Buy | 10 |
| Hold | 6 |
| Sell | 0 |
| Strong sell | 0 |
| Consensus | Buy |
22 analysts cover GEHC.
GE HealthCare Technologies Inc. EPS and revenue estimates
GEHC shows the next fiscal years with at least three analysts: 2026 EPS $5.02, 2027 EPS $5.52. A thinner year is left off this table.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $5.02 | $21.87B |
| 2027 | $5.52 | $22.94B |
Is GE HealthCare Technologies Inc. a buy or sell?
Of the 22 analysts covering GE HealthCare Technologies Inc., 16 rate it a buy (6 strong buy and 10 buy), 6 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).
The GEHC consensus label is Buy, beside 16 buy-side ratings and 0 sell-side ratings.
The average target of $81.14 implies -2.3% versus the current price of $83.02.
Those 22 ratings on GEHC are a headcount, and the label on file is Buy.
Reading the GE HealthCare Technologies Inc. forecast
The GEHC target band runs from $67.00 to $95.00. The average inside that band is $81.14.
Set next to the $83.02 GEHC quote, that average is -2.3%.
Ratings on the GE HealthCare Technologies Inc. cluster: 16 of 22 analysts are on the buy side, 6 are at hold, and 0 are on the sell side, and the published consensus is Buy.
GEHC targets have not moved much: $90.00 recently, $91.00 across the quarter.
22 analysts publish on GEHC, so one note does not swing the average by itself.
GE HealthCare Technologies Inc. forecast questions
What is the GEHC price target?
The published range for GEHC is $67.00 to $95.00, with an average of $81.14. That average is -2.3% versus the current price of $83.02.
Is GE HealthCare Technologies Inc. a buy or sell?
Of the 22 analysts covering GE HealthCare Technologies Inc., 16 rate it a buy, 6 rate it a hold, and 0 rate it a sell. The consensus is Buy, and the GEHC headcount is 16 buy, 6 hold, and 0 sell.
What is the EPS estimate for GE HealthCare Technologies Inc.?
Analyst EPS estimates for GE HealthCare Technologies Inc.: 2026 $5.02, 2027 $5.52.
What is the revenue estimate for GE HealthCare Technologies Inc.?
Analyst revenue estimates for GE HealthCare Technologies Inc.: 2026 $21.87B, 2027 $22.94B.
How many analysts cover GEHC?
22 analysts cover GEHC. Their consensus on GEHC is Buy, across those 22.